Track SYRE and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
SYRE - Spyre Therapeutics Inc. (SYRE) has a earnings per share of -$0.74, down 23.3% over the past year.
Latest EPS (Actual)
-$0.74
Beat Rate
75.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.64 | -$0.74 | Miss | -14.84% |
| Feb 2026 | -$0.80 | -$0.74 | Beat | +7.50% |
| Nov 2025 | -$0.74 | -$0.15 | Beat | +79.73% |
| Aug 2025 | -$0.71 | -$0.49 | Beat | +30.99% |
| May 2025 | -$0.84 | -$0.60 | Beat | +28.57% |
| Feb 2025 | -$0.94 | -$0.81 | Beat | +14.22% |
| Nov 2024 | -$0.86 | -$1.36 | Miss | -58.14% |
| Aug 2024 | -$0.91 | -$0.86 | Beat | +5.49% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.